Background. Over the past ten years, the incidence rate of papillary thyroid carcinoma (PTC)
worldwide has been increasing rapidly year by year, with the incidence rate increasing 6 …

An association between the BRAFV600E mutation and the clinicopathological progression
of papillary thyroid microcarcinoma (PTMC) has been suggested. We aimed to summarize …

Papillary thyroid carcinoma (PTC), the most common malignancy of the endocrine system, is
frequently driven by BRAF V600E mutation, which was reported in 35–60% cases in …

Simple Summary Histopathological diagnosis is prone to significant observer variation in the
diagnosis of papillary thyroid carcinomas (PTCs) due to different thresholds of malignancy …

Objective: To evaluate the relationship between the BRAF V600E mutation in lymph node
metastasis (LNM) and its invasive characteristics in papillary thyroid cancer (PTC). Material …

Background Identifying the high recurrence group of patients with early-stage papillary
thyroid cancer (PTC) is the greatest challenge in the management of this disease. It has …

Background Studies on the relationship between BRAF V600E mutation and the
clinicopathologic features of papillary thyroid carcinoma (PTC), risk of lymph node …

Evidence regarding cancer risk after borderline ovarian tumors (BOTs) is limited. We
conducted a nationwide cohort study examining the incidence of nonovarian cancers in …

Background Associations between different cancer types are known. The affirmation of the
risk for non-ovarian cancer after ovarian borderline tumors (BOT) is, however, sparse. Aim …

Gene mutations could predict the tumor progression and prognosis, which are us to predict
CLNM in patients with cN0 PTC, however, these results are not consistent. This meta …